Get started
Author

Ratchada Cressey

Observed names: Cressey, Ratchada, RATCHADA CRESSEY
ORCID: 0000-0003-4346-4422
Observed ORCID: 0000-0003-4346-4422
OpenAlex ID: A5076021643
Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis
2005 · Ratchada Cressey, Onusa Wattananupong, et al. · BMC Cancer · 45
PDF
Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women
2009 · Jaewwaew Klinchid, Busyamas Chewaskulyoung, et al. · Cancer Genetics and Cytogenetics · 42
Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)
2019 · Paul K Drain, Rachel W Kubiak, et al. · Clinical Infectious Diseases · 38
A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study
2017 · Tim R. Cressey, Oraphan Siriprakaisil, et al. · BMC Infectious Diseases · 25
PDF
Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression
2005 · Ratchada Cressey, Sarunya Pimpa, et al. · Cancer Letters · 25
Daily consumption of banana marginally improves blood glucose and lipid profile in hypercholesterolemic subjects and increases serum adiponectin in type 2 diabetic patients.
2014 · Ratchada Cressey, Warunee Kumsaiyai, et al. · PubMed · 23
Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancer
2025 · Lulu Zhang, Xiyuan Guo, et al. · Frontiers in Immunology · 20
PDF
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
2020 · Tim R. Cressey, Oraphan Siriprakaisil, et al. · International Journal of Infectious Diseases · 19
PDF
Knockout of glucosidase II beta subunit inhibits growth and metastatic potential of lung cancer cells by inhibiting receptor tyrosine kinase activities
2019 · Worapong Khaodee, Suruk Udomsom, et al. · Scientific Reports · 18
PDF
Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients
2008 · Ratchada Cressey, Saranya Pimpa, et al. · BMC Biotechnology · 18
PDF
Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring
2022 · Xin Niu, Rachel W Kubiak, et al. · Open Forum Infectious Diseases · 16
PDF
Glucosidase II beta subunit (GluIIβ) plays a role in autophagy and apoptosis regulation in lung carcinoma cells in a p53-dependent manner
2017 · Worapong Khaodee, Nichanan Inboot, et al. · Cellular Oncology · 16
Glucosidase II exhibits similarity to the p53 tumor suppressor in regards to structure and behavior in response to stress signals: A potential novel cancer biomarker
2013 · BENJAMART SURADEJ, SUPANSA PATA, et al. · Oncology Reports · 16
PDF
Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study
2021 · Adrie Bekker, Helena Rabie, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 15
Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trial
2025 · Adrie Bekker, Nicolas Salvadori, et al. · The Lancet HIV · 13
Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial
2024 · Adrie Bekker, Nicolas Salvadori, et al. · The Lancet HIV · 12
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir Study
2025 · Tim R. Cressey, Nicolas Salvadori, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 9
Navigating PRKCSH’s impact on cancer: from N-linked glycosylation to death pathway and anti-tumor immunity
2024 · Ratchada Cressey, Moe Thi Thi Han, et al. · Frontiers in Oncology · 7
PDF
Transcriptomic analysis of glucosidase II beta subunit (GluIIß) knockout A549 cells reveals its roles in regulation of cell adhesion molecules (CAMs) and anti-tumor immunity
2024 · Worapong Khaodee, Guo Xiyuan, et al. · BMC Genomics · 7
PDF
Beneficial Effects of Macaroni Made with Resistant Starch Type 4 from Unripe Banana and Turmeric Extract on Blood Clinical Chemistry and Gut Microbiota of Healthy Rats
2021 · Wongsakan Chuathong, Wathinee Phomsakha Na Sakonnakhon, et al. · Journal of Food and Nutrition Research · 4
Exploring Small-Molecule Inhibitors of Glucosidase II: Advances, Challenges, and Therapeutic Potential in Cancer and Viral Infection
2025 · Tay Zar Myo Oo, Yupanun Wuttiin, et al. · International Journal of Molecular Sciences · 3
PDF
PRKCSH deficiency promotes an anti-tumor immune microenvironment via UPR activation and M1 macrophage polarization
2025 · Guo Xiyuan, Worapong Khaodee, et al. · Cancer Cell International · 3
Small RNA Deep Sequencing of Circulating Small RNAs Discovers a Unique Panel of microRNAs as Feasible and Reliable Biomarkers of Non-Small Cell Lung Cancers in Northern Thailand
2023 · Moe Thi Thi Han, Sakorn Pornprasert, et al. · Asian Pacific Journal of Cancer Prevention · 3
Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus
2021 · Geoffroy Liegeon, Nicole Ngo-Giang-Huong, et al. · Journal of Antimicrobial Chemotherapy · 3
Expression of cyclooxygenase-1 and -2 and clinicopathologic features of colorectal cancer in northern Thailand.
2004 · Seksan Sankhasard, Nirush Lertprasertsuk, et al. · PubMed · 2
Works count: 45
Citation count: 405
H-index: 14
I10-index: 16
Year
Topic
Type